- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Zirconium-89-labelled rituximab PET-CT in orbital inflammatory disease ; volume:9 ; number:1 ; day:30 ; month:7 ; year:2019 ; pages:1-7 ; date:12.2019
EJNMMI Research ; 9, Heft 1 (30.7.2019), 1-7, 12.2019
- Creator
-
Laban, Kamil G.
Kalmann, Rachel
Leguit, Roos J.
Keizer, Bart de
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-019-0530-9
- URN
-
urn:nbn:de:101:1-2019122504374884545436
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Laban, Kamil G.
- Kalmann, Rachel
- Leguit, Roos J.
- Keizer, Bart de
- SpringerLink (Online service)
Other Objects (12)
Zirconium-89 labelled rituximab PET-CT imaging of Graves’ orbitopathy
B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients
Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe
Rituximab for treatment of non-infectious and non-malignant orbital inflammatory disease
Zirconium.
Zirconium
Gallium-68 labelled RGD PET/CT imaging of endothelial activation in COVID-19 patients
Labelled love
Labelled superposition
Labelled splitting
In vitro studies of 223Ra- and 225Ac-labelled α-zirconium phosphate as potential carrier for alpha targeted therapy
24 Zirconium.
Zirconium-89 labelled rituximab PET-CT imaging of Graves’ orbitopathy
B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients
Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe
Rituximab for treatment of non-infectious and non-malignant orbital inflammatory disease
Zirconium.
Zirconium
Gallium-68 labelled RGD PET/CT imaging of endothelial activation in COVID-19 patients
Labelled love
Labelled superposition
Labelled splitting
In vitro studies of 223Ra- and 225Ac-labelled α-zirconium phosphate as potential carrier for alpha targeted therapy
24 Zirconium.
Zirconium-89 labelled rituximab PET-CT imaging of Graves’ orbitopathy
B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients
Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe
Rituximab for treatment of non-infectious and non-malignant orbital inflammatory disease
Zirconium.
Zirconium
Gallium-68 labelled RGD PET/CT imaging of endothelial activation in COVID-19 patients
Labelled love
Labelled superposition
Labelled splitting
In vitro studies of 223Ra- and 225Ac-labelled α-zirconium phosphate as potential carrier for alpha targeted therapy